Cite

HARVARD Citation

    Wagemann, J. et al. (2022). A new therapeutic approach with tocilizumab in a 39-year-old patient with recurrent diabetic myonecrosis. Modern rheumatology case reports. 6 (1), pp. 59-63. [Online]. 
  
Back to record